Catalyst Wire Dossier Catalyst Wire Dossier

Valbenazine (Ingrezza)

valbenazine · Neurocrine Biosciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Valbenazine (Ingrezza), covering 2024-10-24 to 2024-10-24. Get the full timeline:

Most recent: Clinical Trial Update: Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities [Phase 4]

See pricing